Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 3/20 | 0.43 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | POLB | P06746 | 2/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.43 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | PTBP1 | P26599 | 1/20 | 0.43 |
| ▸ | RCE1 | Q9Y256 | 1/20 | 0.43 |
| ▸ | MET | P08581 | 1/20 | 0.43 |
| ▸ | HTR3A | P46098 | 1/20 | 0.41 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.41 |
| ▸ | GPR3 | P46089 | 1/20 | 0.40 |
| ▸ | EGFR | P00533 | 4/20 | 0.40 |
| ▸ | TYMS | P04818 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | MEN1 | O00255 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL841678 | 0.82 | KDM4E (0.57) | KDM4EALDH1A1KMT2ALMNANPC1 | |
| SCHEMBL11516897 | 0.77 | KDM4E (0.64) | KDM4EALDH1A1KMT2ALMNANPC1 | |
| SCHEMBL27997404 | 0.76 | ALDH1A1 (0.50) | KDM4EALDH1A1KMT2ALMNANPC1 | |
| SCHEMBL14742590 | 0.76 | CTDSP1 (0.57) | KDM4EALDH1A1KMT2ALMNANPC1 | |
| SCHEMBL21409753 | 0.73 | KMT2A (0.45) | KDM4EALDH1A1KMT2ALMNANPC1 | |
| SCHEMBL19445131 | 0.72 | KDM4E (0.54) | KDM4EALDH1A1KMT2ALMNANPC1 | |
| SCHEMBL8628036 | 0.71 | KMT2A (0.70) | KDM4EALDH1A1KMT2ALMNANPC1 | |
| Hydrochloric Acid SCHEMBL28888962 | 0.70 | KMT2A (0.68) | KDM4EALDH1A1KMT2ALMNANPC1 | |
| SCHEMBL6151918 | 0.69 | KDM4E (0.64) | KDM4EALDH1A1KMT2ALMNANPC1 | |
| SCHEMBL29405526 | 0.69 | CTDSP1 (0.63) | KDM4EALDH1A1KMT2ALMNANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 272 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2009032172-A2 | PLATINUM COMPOSITIONS AS TREATMENT FOR OCT-RELATED CANCERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2009-03-12 | — | — | WO | claimed |
| US-12544491-B2 | In situ forming hemostatic foam implants | ARSENAL MEDICAL, INC. (US) | 2026-02-10 | — | — | US | disclosed |
| EP-3922187-B1 | IN SITU FORMING HEMOSTATIC FOAM IMPLANTS | ARSENAL MEDICAL INC (US) | 2026-01-07 | — | — | EP | disclosed |
| US-20250242063-A1 | METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF | LANTHEUS MEDICAL IMAGING, INC. (US) | 2025-07-31 | — | — | US | disclosed |
| US-20250170283-A1 | COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS | LANTHEUS MEDICAL IMAGING, INC. (US) | 2025-05-29 | — | — | US | disclosed |
| US-20250171398-A1 | COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS | LANTHEUS MEDICAL IMAGING, INC. (US) | 2025-05-29 | — | — | US | disclosed |
| US-20250170282-A1 | COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS | LANTHEUS MEDICAL IMAGING, INC. (US) | 2025-05-29 | — | — | US | disclosed |
| US-12300434-B2 | High yield storage materials | PolyJoule, Inc. (US) | 2025-05-13 | — | — | US | disclosed |
| US-12243664-B2 | Triazine-based polymer | PolyJoule, Inc. (US) | 2025-03-04 | — | — | US | disclosed |
| US-20250019381-A1 | PROCESS FOR THE SYNTHESIS OF 6-((3S,4S)-4-METHYL-1-(PYRIMIDIN-2-YLMETHYL)PYRROLIDIN-3-YL)-3-(TETRAHYDROPYRAN-4-YL-7H-IMIDAZO[1,5-a]PYRAZIN-8-ONE | CARDURION PHARMACEUTICALS, INC. | 2025-01-16 | — | — | US | disclosed |
| WO-2011109276-A1 | EPOXIDATION CATALYSTS | MASSACHUSSETS INSTITUTE OF TECHNOLOGY (US) | 2011-09-09 | — | — | WO | disclosed |
| US-20110202016-A1 | SYSTEMS AND METHODS RELATING TO POLYMER FOAMS | ARSENAL MEDICAL, INC. (US) | 2011-08-18 | — | — | US | disclosed |
| WO-2011097649-A2 | METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF | LANTHEUS MEDICAL IMAGING, INC. (US) | 2011-08-11 | — | — | WO | disclosed |
| US-20110118469-A1 | CONTINUOUS FLOW SYNTHESIS OF AMINO ALCOHOLS USING MICROREACTORS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2011-05-19 | — | — | US | disclosed |
| WO-2011056929-A1 | CONTINUOUS FLOW SYNTHESIS OF AMINO ALCOHOLS USING MICROREACTORS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2011-05-12 | — | — | WO | disclosed |
| US-20100316998-A1 | METHODS AND COMPOSITIONS FOR EMPIRICAL SELECTION OF DRUGS OR OTHER MOLECULES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2010-12-16 | — | — | US | disclosed |
| WO-2010047765-A2 | NANOSTRUCTURES FOR DRUG DELIVERY | MASSACHUSSETTS INSTITUTE OF TECHNOLOGY (US) | 2010-04-29 | — | — | WO | disclosed |
| WO-2010027428-A1 | PLATINUM ( IV) COMPLEXES FOR USE IN DUAL MODE PHARMACEUTICAL THERAPY | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2010-03-11 | — | — | WO | disclosed |
| WO-2009032172-A2 | PLATINUM COMPOSITIONS AS TREATMENT FOR OCT-RELATED CANCERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2009-03-12 | — | — | WO | disclosed |
| US-20080138292-A1 | Sensors for fluorescence and magnetic resonance imaging | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2008-06-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (10 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250170283-A1 | COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS | FABP3, TNNI3, TNNT2 | KDM4E 4378/4885ALDH1A1 3040/4885KMT2A 4341/4885 |
| US-20250242063-A1 | METHODS AND APPARATUS FOR SYNTHESIZING IMAGING AGENTS, AND INTERMEDIATES THEREOF | TNNI3, FABP3, MPI | KDM4E 3124/4885ALDH1A1 1208/4885KMT2A 4371/4885 |
| US-20100316998-A1 | METHODS AND COMPOSITIONS FOR EMPIRICAL SELECTION OF DRUGS OR OTHER MOLECULES | ABCG2, MRPS34, PIGO | KDM4E 4739/4885ALDH1A1 2126/4885KMT2A 4845/4885 |
| US-20110118469-A1 | CONTINUOUS FLOW SYNTHESIS OF AMINO ALCOHOLS USING MICROREACTORS | ADH1C, ADH1A, ADH5 | KDM4E 1181/4885ALDH1A1 34/4885KMT2A 651/4885 |
| US-12544491-B2 | In situ forming hemostatic foam implants | F9, F12, F2 | KDM4E 2509/4885ALDH1A1 3891/4885KMT2A 4236/4885 |
| US-20250171398-A1 | COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS | FABP3, TNNI3, TNNT2 | KDM4E 2553/4885ALDH1A1 732/4885KMT2A 2531/4885 |
| US-20080138292-A1 | Sensors for fluorescence and magnetic resonance imaging | CA2, SLC30A6, SLC39A3 | KDM4E 4147/4885ALDH1A1 3462/4885KMT2A 3742/4885 |
| US-12243664-B2 | Triazine-based polymer | PARG, TPR, PARN | KDM4E 2943/4885ALDH1A1 1852/4885KMT2A 992/4885 |
| US-20250170282-A1 | COMPOSITIONS, METHODS, AND SYSTEMS FOR THE SYNTHESIS AND USE OF IMAGING AGENTS | FABP3, TNNI3, TNNT2 | KDM4E 3637/4885ALDH1A1 2699/4885KMT2A 3430/4885 |
| US-20250019381-A1 | PROCESS FOR THE SYNTHESIS OF 6-((3S,4S)-4-METHYL-1-(PYRIMIDIN-2-YLMETHYL)PYRROLIDIN-3-YL)-3-(TETRAHYDROPYRAN-4-YL-7H-IMIDAZO[1,5-a]PYRAZIN-8-ONE | CDK8, PRMT8, DHPS | KDM4E 869/4885ALDH1A1 2427/4885KMT2A 1389/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.